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Introduction
An aneurysmal subarachnoid hemorrhage (a-SAH) is a subtype 
of stroke caused by a ruptured intracranial aneurysm.1 The inci-
dence rates have remained stable over decades ranging from 6 
to 8 per 100,000 person-years.1,2It is reported that a-SAH has 
long-term consequences such as fatigue, depressive symptoms 
and problems in cognitive functioning that may persist four 
years post-onset.3,4 Furthermore, half of the patients experience 
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ABSTRACT
Background: Peak oxygen uptake (VO2peak) established during progressive cardiopulmonary exercise 
testing (CPET) is the “gold-standard” for cardiorespiratory fitness. However, CPET measurements may be 
limited in patients with aneurysmal subarachnoid hemorrhage (a-SAH) by disease-related complaints, 
such as cardiovascular health-risks or anxiety. Furthermore, CPET with gas-exchange analyses require 
specialized knowledge and infrastructure with limited availability in most rehabilitation facilities.
Objectives: To determine whether an easy-to-administer six-minute walk test (6MWT) is a valid clinical 
alternative to progressive CPET in order to predict VO2peak in individuals with a-SAH.
Methods: Twenty-seven patients performed the 6MWT and CPET with gas-exchange analyses on a cycle 
ergometer. Univariate and multivariate regression models were made to investigate the predictability of 
VO2peak from the six-minute walk distance (6MWD).
Results: Univariate regression showed that the 6MWD was strongly related to VO2peak (r = 0.75, p < 0.001), 
with an explained variance of 56% and a prediction error of 4.12 ml/kg/min, representing 18% of mean 
VO2peak. Adding age and sex to an extended multivariate regression model improved this relationship 
(r  =  0.82, p  <  0.001), with an explained variance of 67% and a prediction error of 3.67  ml/kg/min 
corresponding to 16% of mean VO2peak.
Conclusions: The 6MWT is an easy-to-administer submaximal exercise test that can be selected to 
estimate cardiorespiratory fitness at an aggregated level, in groups of patients with a-SAH, which may help 
to evaluate interventions in a clinical or research setting. However, the relatively large prediction error does 
not allow for an accurate prediction in individual patients.
© 2016 The author(s). published by informa Uk limited, trading as Taylor & Francis Group.
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problems in resuming previous activities, 64% report on one or 
more participation restrictions, and only one-third is able to fully 
resume their previous occupation.4–7
Previously, we showed that the cardiorespiratory fitness was 
approximately 30% lower in patients with a-SAH compared to 
control subjects.8 The beneficial health effects of improved car-
diorespiratory fitness in individuals with stroke, not caused by 
a-SAH, are well-recognized and exercise training has become 
 OPEN ACCESS
TOPICS IN STROKE REHABILITATION  251
laboratory abnormality that may interfere with the outcome 
of the study. Additional exclusion criteria regarding the CPET 
measurements were: aged ≥70  years, and absolute contra- 
indication for CPET.
Procedure
Contra-indications and health risks for physical exercise testing 
were examined by the treating physician using the guidelines for 
exercise testing and prescription, established by the American 
College of Sports Medicine (ACSM)26 and the Physical Activity 
Readiness Questionnaire (PAR-Q).27 Hereafter, the 6MWT and 
progressive CPET were performed sequentially in this order. 
Sufficient resting periods were provided between the tests. A 
sports physician served as an emergency back-up during the 
progressive CPET.
Six-minute walk test
The 6MWT is an easy-to-administer submaximal exercise test 
and was applied as described by the American Thoracic Society.28 
The 6MWT showed good to excellent test–retest reliability after 
stroke.29 Participants were instructed to walk as far as they could 
along a 30-m indoor, continuous track with a hard surface during 
a 6-min period. The 6MWT was not practiced beforehand, since 
this resembles clinical practice. Consistent encouragement was 
provided after each minute. Participants were allowed to take rest 
during the test, but were instructed to resume walking as soon as 
they were able to do so.28 The 6MWD (m) was registered at the 
end of the test. Heart rate (HR) was recorded using a HR monitor.
Cardiopulmonary exercise test
Progressive CPET was performed on an electronically braked 
cycle ergometer, which is considered feasible and safe in indi-
viduals with stroke who underwent pre-test medical screening.30 
A ramp protocol was implemented which was preceded by a 
four-min warm-up. Hereafter, the resistance increased every 10 
s (for females: 12 W/min, for males: 16 W/min) to ensure that 
volitional exhaustion was reached within 8–14 min. The partici-
pants were instructed to pedal at a rate of 60–70 revolutions/min. 
CPET was terminated when participants voluntary stopped or 
were unable to maintain the target pedal rate. CPET could also 
be terminated because of increased health risks, as prescribed in 
the guidelines of the ACSM.31
During progressive CPET, blood pressure was measured for 
safety reasons using an automatic system, and heart function 
was monitored continuously with a 12-lead electrocardiogram. 
Gas-exchange analyses were applied by indirect calorimetry 
using a breath-by-breath oximetry analysing system. Before each 
measurement, volume and gas calibrations were performed. 
VO2peak was defined as the highest mean oxygen uptake during 
30 s of exercise and was expressed in absolute VO2peak (mL/min) 
and VO2peak per kg body mass (mL/kg/min).
The following criteria were used to objectively determine 
the performance of maximal exercise testing: (1) respiratory 
exchange ratio (RER) > 1.0,32 or (2) peak heart rate (HRpeak) 
within 10 beats per minute (bpm) of the age-predicted maximum 
heart rate (HRmax), calculated from the formula of Tanaka et al.: 
an integral component of stroke rehabilitation.9–11 However, 
the benefits of improved cardiorespiratory fitness remain to be 
established in individuals with a-SAH. The assessment of cardi-
orespiratory fitness may help to target and improve rehabilitation 
programs for individuals with a-SAH.
The gold standard for measuring cardiorespiratory fitness is 
peak oxygen uptake (VO2peak) obtained with indirect calorimetry 
during progressive cardiopulmonary exercise testing (CPET).12 
However, disease-related complaints, such as cardiovascular 
health risks or anxiety, may limit the use of progressive CPET 
in individuals with a-SAH.13,14 Moreover, progressive CPET 
measurements with gas-exchange analyses require specialized 
knowledge and infrastructure, with limited availability in most 
rehabilitation facilities.
The six-minute walk test (6MWT) is an easy-to-administer 
submaximal exercise test, in which the covered distance walked 
within six minutes is measured.15 The six-minute walk distance 
(6MWD) is found to be predictive of VO2peak in patients with 
cardiopulmonary disorders.16–18 In patients with stroke, not 
caused by a-SAH, the 6MWD seems to be less predictive of 
VO2peak. Associations between 6MWD and VO2peak range from 
0.34 to 0.74.19 The 6MWD seems to be determined more by 
impaired walking capacity, than by limited VO2peak.19–22 Because 
patients with a-SAH usually do not suffer from impairments that 
directly affect walking capacity,23,24 the 6MWD may be more 
indicative of VO2peak in these patients. If this is so, the 6MWT 
may be an easy-to-use instrument to assess cardiorespiratory 
fitness after a-SAH and will be of great value in daily clinical 
practice.
The present study investigates the relationship between the 
6MWD and VO2peak, and examines whether the 6MWD can pre-
dict VO2peak in individuals with a-SAH. We hypothesize that the 




This cross-sectional study, entitled HIPS-Rehab, was part of the 
longitudinal observational study: “Hypopituitarism In Patients 
after Subarachnoid hemorrhage study (HIPS)”.25 The present 
study describes measures of physical fitness that were obtained 
six months after a-SAH. The study was approved by the Medical 
Ethics Committee of the Erasmus University Medical Center, and 
all participants gave written informed consent.
Individuals with a-SAH admitted to the department of 
Neurology of the Erasmus Medical Center between June 2009 
and June 2012 were eligible for inclusion when they were dis-
charged from the Intensive Care Unit and aged ≥18  years. 
Diagnosis of a-SAH was confirmed by computerized tomog-
raphy (CT) of the brain and, in cases with negative CT, by 
lumbar puncture. Presence and location of the aneurysm was 
determined by CT angiography and/or a digital subtraction 
angiography.
Excluded from the study were patients meeting any of the 
following criteria: (1) hypothalamic or pituitary disease diag-
nosed prior to a-SAH; (2) history of cranial irradiation; (3) 
trauma capitis prior to a-SAH; (4) other intracranial lesion apart 
from a-SAH; or (5) other medical or psychiatric condition or 
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HRmax = 208−[0.7 × age ].33 As β-blocker medication reduces 
HRmax by 25–30%, the equation was adjusted for those with 
β-blocker medication: HRmax = 0.7 [208−(0.7 × age)].30
Clinical characteristics
The following clinical characteristics were collected to describe 
the study population: World Federation of Neurologic Surgeons 
(WFNS) grade,34 Glasgow Coma Scale (GCS) score,35 location 
of aneurysm, treatment modality of the aneurysm, and pres-
ence of hypopituitarism (yes/no) or hydrocephalus (yes/no). 
Additionally, neurologic comorbidity (paresis or spasticity) 
was examined and body mass index (BMI) was calculated from 
height and body mass (kg/m²).
Statistical analyses
Participants that met the objective criteria for maximal exercise 
testing were included in the final analyses. All data are expressed 
as mean (SD) unless otherwise indicated. The assumptions for 
normality and linear regression analysis were met. In order 
to compare clinical characteristics of participants versus non- 
participants, independent t-tests were used for continuous data 
and chi-square tests for categorical data.
A univariate linear regression model was performed using 
VO2peak as dependent variable and 6MWD (m) as independent 
variable. In a multivariate linear regression model age and sex 
were added using step-wise regression with variables being added 
in a forward model. The explained variance (r2) and the corre-
lation coefficient (r) were analyzed. Although there are no hard 
rules to describe correlational strength, we considered a correla-
tion coefficient of r > 0.70 as a strong correlation, representing a 
good estimation of VO2peak from 6MWD at an aggregated group 
level.36 Furthermore, the standard error of the estimate (SEE), 
as a percentage of mean VO2peak was calculated to analyze the 
magnitude of the prediction error which reflects the prediction 
accuracy at an individual level.
Additionally, paired samples t-test was used to compare the 
6MWD with normative values which were calculated from the 
formula established by Enright et al.37 All analyses were per-
formed using IBM SPSS Statistics, version 20, and a probability 
value of p < 0.05 was considered statistically significant.
Results
Between June 2009 and June 2012, 241 patients were admit-
ted to the ICU with a diagnosis of a-SAH, 84 were included in 
HIPS from which 52 volunteered to participate in HIPS-Rehab. 
Participants in HIPS-Rehab (n = 52) did not differ from non- 
participants (n  =  32) with regard to: sex (p  =  0.291), age 
(p = 0.996), WFNS-grade (p = 0.505) and GCS score at admis-
sion (p = 0.136), the location of the aneurysm (p = 0.469), the 
administered treatment modality (p = 0.489), and the presence 
of hypopituitarism (p = 0.353) or hydrocephalus (p = 0.559).
In total, 27 successful measurements of both 6MWT and 
CPET were analyzed (52%). Of the original sample nine patients 
were aged >70 years, seven could not perform CPET because 
of logistic reasons, five showed absolute contraindications 
to CPET, two did not meet the objective criteria for maximal 
physical exertion, one was not able to perform CPET because of 
an additional injury and another one could not perform 6MWT 
because of visual impairment. Although participants included in 
the analyses were younger (mean age difference 6.8 years, 95% 
CI −12.94 to −0.057, p = 0.033), there were no significant differ-
ences compared to those who were excluded. Table 1 presents 
characteristics of the participants. The majority had a ruptured 
aneurysm in the anterior circulation (63%), most underwent 
endovascular coiling (78%), and 23 (85%) were graded to WFNS 
I or II with a mean GCS score of 13.7 (2.3). Participants did not 
show neuro–motor deficits such as paresis or spasticity.
Although 21 participants (78%) had an increased health risk 
for physical exercise, there were no serious unexpected side- 
effects observed during or after the 6MWT or the progressive 
CPET. Outcome measures of 6MWT and CPET are presented 
in Table 2. Mean 6MWD was 498 (98) m, which is significantly 
lower than the calculated mean norm values (=557 (70) m; 95% 
CI for the difference = −99.1 to −18.6, p = 0.006). HR at the end of 
6MWT was 114 (20) bpm, reflecting 67% of predicted maximum 
HR (= 171 (6) bpm). Results for CPET measurement showed a 
mean VO2peak of 22.3 (6.0) mL/kg/min, with a mean HRpeak of 
152 (24) bpm, reflecting 89% of predicted HRmax (= 171 (6) 
bpm). The univariate linear regression model, with VO2peak as 
dependent variable and 6MWD as independent variable revealed 
a strong relationship (r = 0.75, B = 0.05, 95% CI for B = 0.03–0.06, 
p < 0.001), with an explained variance of 56% (Table 3). SEE was 
4.12  ml/kg/min, representing 18% of mean VO2peak. Figure 1 
shows the relationship between VO2peak and 6MWD.
The extended multivariate linear regression model was sig-
nificant (p < 0.001), with an explained variance of 67% and a 
SEE of 3.67  ml/kg/min, representing 16% of mean VO2peak 
(Table 4). In addition to 6MWD (B  =  0.04, 95% CI for 
Table 1. clinical characteristics.
note: bMi, body Mass index (kg/m2); WFns grade, World Federation of neurologic 
surgeons grading system for subarachnoid hemorrhage scale.
*endovascular treatment is also known as coiling. 
Individuals with a-SAH (n = 27)
Characteristics
sex, male n (%) 8 (30%)
age (years) 53.0 (8.9)
Weight (kg) 74.8 (10.3)
bMi (kg/m²) 25.9 (3.7)
WFNS grade, n (%)
 I 14 (52%)
 II 9 (33%)
 III 0
 IV 3 (11%)
 V 1 (4%)
Glasgow coma scale score 13.7 (2.3)
location aneurysm, n (%)
 anterior circulation 17 (63%)
 posterior circulation 10 (37%)
aneurysm treatment, n (%)
 clipping 6 (22%)
 endovascular treatment* 21 (78%)
complications following a-sah
 hydrocephalus, n (%) 8 (30%)
 Growth hormone Deficiency, n (%) 2 (7%)
 re-bleed 0 
 Delayed cerebral ischemia 3 (11%)
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error representing 16% of mean VO2peak. Since post-stroke exer-
cise programs improve cardiorespiratory fitness by 9–23%,38 we 
consider the prediction error of 16% too large to accurately pre-
dict VO2peak at an individual level. However, the 6MWT can be 
used to predict cardiorespiratory fitness at an aggregated level in 
groups of patients with a-SAH in clinical and research settings.
According to Outermans et al., correlation coefficients 
between VO2peak and 6MWD in patients with stroke, not caused 
by a-SAH, range from 0.34 to 0.74.19 They showed that the rela-
tionship is more determined by balance problems and neu-
ro-motor impairments, which affect the walking ability, than by 
a limited VO2peak.19,20 Patterson et al. found that the variance in 
6MWD in individuals with stroke was explained by VO2peak for 
those who walked more quickly, and by balance for those who 
walked more slowly.39 In the present study, the relatively strong 
relationship between 6MWD and VO2peak can be explained by the 
fact that individuals with a-SAH have relatively mild neurologic 
morbidity that did not affect the walking ability.
The present findings are in line with studies in patients with 
cardiopulmonary disorders. Studies reported correlation coef-
ficients for the relationship between 6MWD and VO2peak that 
ranges from 0.68 to 0.82.40–42 Ross et al.17 studied the predictabil-
ity of VO2peak from the 6MWD by analyzing the magnitude of the 
SEE across 10 different studies, including 1,083 cardiopulmonary 
patients. They recognized moderate-to-strong relationships and 
reported on poor prediction accuracies as well; they concluded 
that the 6MWT can be used to estimate mean VO2peak at an 
aggregated level, but that the 6MWT cannot predict VO2peak at 
an individual level.
In patients with a-SAH, the mean 6MWD was found to be 
498 m, which is higher compared to individuals with other types 
of stroke (6MWD ranging from 216 to 401 m).19 However, the 
mean 6MWD is 25% lower compared to that of sex and age-
matched norm values, suggesting compromised cardiorespira-
tory fitness.37
Five participants had absolute contra-indications for pro-
gressive CPET and the majority had increased health risks for 
B = 0.03–0.06, p < 0.001), age significantly contributed to the 
prediction of VO2peak (B = −0.21, 95% CI for B = −0.38 to −0.04, 
p = 0.017), whereas sex did not (B = 1.52, 95% CI for B = −1.76 
to 4.80, p = 0.349).
Discussion
The present study examined whether the 6MWT is a valid alter-
native to progressive CPET to predict the cardiorespiratory fit-
ness after a-SAH. A significant, strong correlation was found 
between the 6MWD and VO2peak (r = 0.82), with a prediction 
Figure 1. relationship between peak oxygen uptake (Vo2peak) and six-min walk distance.
Table 2. results of the six-min walk test and cardiopulmonary exercise test.
note: 6MWT, six-min walk test; 6MWD, six-min walk distance; hr, heart rate; bpm, 
beats per minute; Vo2peak, peak oxygen uptake; Vepeak, peak minute ventilation; 
hrpeak, peak heart rate; rer, respiratory exchange ratio.
Individuals with a-SAH (n = 27)
6MWT
6MWD (m) 498 (98)
hr (bpm) 114 (20)
CPET
Time until Vo2peak (min:sec) 09:45 (01:50)
Vo2peak (ml/min) 1664.4 (500.8)
Vo2peak (ml/kg/min) 22.3 (6.0)
Vepeak (l/min) 70.4 (23.7)
Maximum load (W) 132.9 (44.7)
hrpeak (bpm) 152 (24)
rer 1.15 (0.08)
Table 3. Univariate linear regression analysis with Vo2peak (ml/kg/min) as depend-
ent variable and the six-min walk distance (6MWD) as independent variable.
notes: ci, confidence interval; see, standard error of the estimates.ŦUnstandard-
ized B-coefficients. Ɨsee expressed as percentage of mean Vo2peak. 
Variable B (95% CI)Ŧ p-value r r2 SEE
(SEE/mean) 
× 100Ɨ
constant −0.70 0.75 0.56 4.12 18%
6MWD (m) 0.05 (0.03 to 
0.06)
<0.001
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physical exercise. This emphasizes the need for safe and valid 
alternatives to progressive CPET after a-SAH. Since the 6MWT 
cannot accurately predict VO2peak at an individual level, stud-
ies are warranted to investigate other options. Future research 
may consider the use of submaximal cycle ergometer proto-
cols. A recently introduced submaximal cycle ergometer test by 
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significantly differ from non-participants (also on WFNS grade 
and GCS score at admission). Finally, for pragmatic reasons, the 
6MWT and the CPET were performed on a single day. Although 
we provided ample resting time, ideally the tests should be per-
formed on separate days to provide sufficient rest between the 
two tests.
Conclusion
The 6MWD was strongly related to VO2peak in patients with 
a-SAH. Therefore, the 6MWT can be used to predict mean 
VO2peak at an aggregated group level. This is relevant for the 
evaluation of therapy programs in the clinical setting and for 
research purposes. However, the prediction error was too large 
to accurately predict VO2peak in individual patients. Since the 
importance of cardiorespiratory fitness is well-recognized in 
stroke rehabilitation, easy-to-administer submaximal exercise 
tests need to be identified, to target and improve post-acute reha-
bilitation programs for individuals with a-SAH.
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